INSULIN SENSITISERS AND METHODS OF TREATMENT

(19)

(11)

EP 2 106 260 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	04.04.2018 Bulletin 2018/14

(45)	Mention of the grant of the patent:
	06.12.2017 Bulletin 2017/49

(21)	Application number: 08700385.1

(22)	Date of filing: 25.01.2008

(51)

International Patent Classification (IPC):

A61K 31/433^(2006.01)
A61K 31/428^(2006.01)
A61P 3/10^(2006.01)

A61K 31/18^(2006.01)
A61P 3/08^(2006.01)
A61P 5/50^(2006.01)

(86)	International application number:
	PCT/AU2008/000089

(87)	International publication number:
	WO 2008/089521 (31.07.2008 Gazette 2008/31)

(54)	INSULIN SENSITISERS AND METHODS OF TREATMENT INSULIN-SENSIBILISATOREN UND BEHANDLUNGSVERFAHREN DAMIT SENSIBILISATEURS A L'IINSULINE ET PROCÉDÉS DE TRAITEMENT

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30)

Priority:

25.01.2007 US 897769 P
17.04.2007 AU 2007902013
31.10.2007 US 984335 P
11.12.2007 US 7376 P

(43)	Date of publication of application:
	07.10.2009 Bulletin 2009/41

(60)	Divisional application:
	17196457.0

(73)	Proprietor: Naia Metabolic, Inc.
	Grand Cayman KY1-1108 (KY)

(72)	Inventors:
	COLLIER, Gregory, Royce Barwon Heads, Victoria 3227 (AU) WALDER, Kenneth, Russell Ocean Grove, Victoria 3226 (AU) CAMPBELL, James, Alexander Newtown, Victoria 3220 (AU) MOLERO-NAVAJAS, Juan-Carlos Grovedale, Victoria 3216 (AU) KONSTANTOPOULOS, Nicky Richmond, Victoria 3121 (AU) KRIPPNER, Guy, Yeoman Newtown, Victoria 3220 (AU)

(74)	Representative: D Young & Co LLP
	120 Holborn London EC1N 2DY London EC1N 2DY (GB)

(56)

References cited: :

WO-A1-97/18808
WO-A1-03/051890
WO-A1-2004/063194
WO-A1-2007/054580
WO-A2-01/47509
WO-A2-02/13800
WO-A2-2005/110413
US-A1- 2004 039 031
US-A1- 2007 110 707

WO-A1-02/051890
WO-A1-03/097045
WO-A1-2005/025558
WO-A1-2007/065948
WO-A2-02/03984
WO-A2-2005/082414
US-A1- 2002 037 861
US-A1- 2005 288 339
US-A1- 2007 111 272

DEMAREST K ET AL: "GLUCOSE TOLERANCE IN ANIMAL MODELS OF TYPE 2 DIABETES MELLITUS GIVEN TOPIRAMATE" DENSHI JOUHOU TSUUSHIN GAKKAI GIJUTSU KENKYUU HOUKOKU // INSTITUTE OF ELECTRONICS, INFORMATION AND COMMUNICATION ENGINEERS. TECHNICAL REPORT, DENSHI JOUHOU TSUUSHIN GAKKAI, JP, vol. 44, no. SUPPL. 01, 1 August 2001 (2001-08-01), page A226, XP008011166 ISSN: 0913-5685
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1980, CHERNYKH V P: "PER ORAL SUCROSE REDUCING SULFAMIDES" XP002575478 Database accession no. PREV198121050915
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1979, CHERNYKH V P ET AL: "HYPO GLYCEMIC ACTIVITY OF AROMATIC SULFO HYDRAZIDES AND THEIR DERIVATIVES" XP002575479 Database accession no. PREV198070053022
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1978, VORONINA L M ET AL: "SOME BIO PHARMACEUTICAL ASPECTS OF BUTAMIDE TABLETS" XP002575481 Database accession no. PREV197967004692
GROSSMAN A J ET AL: "Effects of acetazolamide (Diamox) on blood sugar of normal subjects and diabetic patients", PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY & MEDICINE, ACADEMIC PRESS INC. NEW YORK, US, vol. 93, 1 January 1956 (1956-01-01), pages 255-256, XP003012454, ISSN: 0037-9727

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).